Promoting Positive Body Image in Eating Disorders Through Embodiment‐Based Interventions: A Preliminary Randomized Controlled Trial
International Journal of Eating Disorders · 2026-11-05
DOI: 10.1002/eat.70260 ↗Abstract
ABSTRACT Objective Embodiment‐based interventions may be particularly promising for promoting positive body image in patients with Eating Disorders (EDs). This preliminary randomized controlled trial investigated the effects of two embodiment‐based interventions on positive body image and ED symptoms in outpatients with EDs, compared with standard treatment. Method Forty‐nine outpatients with EDs recruited from a specialist ED service were randomized to one of three conditions: (a) Treatment as Usual (TAU), (b) TAU plus the From Feeling to Seeing the Body intervention (FSB + TAU), or (c) TAU plus Hatha Yoga (YOGA+TAU). Participants completed measures of body appreciation, functionality appreciation, and ED symptoms. Assessments were conducted at baseline, post‐treatment, and 1‐ and 3‐month follow‐ups. Results Significant time × group interactions emerged for functionality appreciation and ED symptoms. FSB + TAU showed significantly higher functionality appreciation than TAU at post‐treatment and 1‐month follow‐up, with within‐group gains maintained throughout the follow‐up period. YOGA + TAU also showed within‐group improvements in functionality appreciation, although these did not differ significantly from TAU in the between‐group analyses. Body appreciation increased over time across all conditions, with no significant between‐group differences. ED symptoms decreased over time in all groups; however, embodiment‐based interventions did not confer additional reductions beyond those associated with TAU. Discussion Embodiment‐based interventions may represent a promising adjunct to standard treatment for promoting positive body image in outpatients with EDs, particularly functionality appreciation, while no add‐on benefits emerged for ED symptoms, supporting the view that positive body image and ED symptoms may represent related but distinct treatment targets.
EUVIMED